Targeted Protein Degradation
Targeted Protein Degradation
批准号:
10540261
负责人:
TERRY L. SHEPPARD
金额:
$2.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-12-01 至 2024-11-30
关键词:
AcademiaAddressAutophagocytosisBiophysicsCell physiologyCellsCellular biologyChemistryClinicalClinical TrialsCollaborationsColoradoComplexCullin ProteinsDegradation PathwayDevelopmentDisciplineEducational workshopEndoplasmic Reticulum Degradation PathwayFosteringFutureGenderGeneticGeographyHeat-Shock ResponseInstitutionKnowledgeLearningLigaseMethodologyModalityModelingMolecular ChaperonesOutcomeParticipantPharmaceutical PreparationsPost-Translational Protein ProcessingProteinsResearchResearch PersonnelScienceScientistStructureStudentsThinkingUbiquitinationcareerclinical practicedrug discoveryexperienceforgingfrontierimprovedinsightinterestmultidisciplinarynext generationnon-Nativenovelnovel therapeuticspostersprogramsprotein degradationprotein protein interactionreceptorskillssmall moleculesymposiumtherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Targeted Protein Degradation, organized by
Drs. James Bradner, Eric Fischer and Brenda Schulman. The conference will be held in Keystone, Colorado
from January 29- February 1, 2023.
This Keystone Symposia conference will focus on advances in the rapidly evolving field of targeted protein
degradation (TPD). Over the past five years, the field has moved from proof of concept to the development of
degrader drugs in clinical trials. Clinical impact has brought a sense of urgency and broadened interest for
formulating and clarifying a new science of degradation. TPD has focused on cullin ring ligases and their
substrate receptors, cereblon and VHL, along with other degradation pathways such as autophagy, ERAD,
heat shock chaperones and monovalent degraders that are emerging as part of the TPD field. Currently small
molecule degraders induce the formation of non-native protein-protein interactions. Elucidation of mechanistic
details that drive ternary complex formation, and the timely sharing of these discoveries, are critical to give the
field momentum and drive it forward. This Keystone Symposia conference will invite leaders in the field, from
around the world, to share insights across diverse disciplines that will provide insight into the biophysics,
chemistry, cell biology and genetic basis for this new science. There will a strong emphasis on renewing the
spirit of face-to-face exchanges among subject matter experts with the idea to maximize interactions, formulate
questions and foster new collaborations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
-
批准号:10682118
-
项目类别:
-
资助金额:$1.53万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
-
批准号:10540260
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
-
批准号:10753451
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Vaccinology During and After COVID-19
-
批准号:10753782
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Transposable Elements at the Crossroads of Evolution, Health and Disease
-
批准号:10750852
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
-
批准号:10749522
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
-
批准号:10683443
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
HIV Vaccines, Immunoprophylaxis and Drugs
-
批准号:10699245
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metastasis
-
批准号:10681132
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Inflammation in the Lung: Friend or Foe in Viral Infections?
-
批准号:10681956
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
-
批准号:10754008
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Myeloid Cell Diversity: From Fundamental Biology to Disease States
-
批准号:10753412
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
RNA Modifications in Health and Disease
-
批准号:10754076
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy
-
批准号:10540496
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
From First Breath: Lung Development, Infection, Repair and Aging
-
批准号:10678811
-
项目类别:
-
资助金额:$1.65万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Precision Genome Engineering
-
批准号:10608865
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
T and B Cell Collaboration in Germinal Centers and Beyond
-
批准号:10753621
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics
-
批准号:10682747
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metabolic and Molecular Mechanisms of NAFLD/NASH
-
批准号:10682156
-
项目类别:
-
资助金额:$1.92万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Heart Development and Disease: From Genes to Cures
-
批准号:10608624
-
项目类别:
-
资助金额:$1.62万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
海外基金